Cluster headaches are part of a neurological disorder that inflicts massive waves of pain. The affected area seems always to be around one of the eyes. A headache is often accompanied by other conditions such as nasal congestion, eye watering, and others. However, there was no effective cure for this kind of disorder mainly because scientists couldn’t discover the cause of such great pains. However, the Food and Drug Administration has just approved a new treatment for episodic such cases.
Treatments for Cluster Headaches
On April 18, FDA gave green light to ElectroCore, a company with the headquarters in New Jersey, to deliver its latest product on the market. This is about GammaCore, a device for vagus nerve stimulation that customers can hold in one hand. This is the first time FDA has ever approved treatment that is primarily intended for cluster headaches. Before GammaCore, patients had to resort to cures for migraines to ease their excruciating pains. These consist mostly of sumatriptan drugs that are taken through an auto-injector or oxygen therapy.
The cluster headache got its name from the fact that a headache never comes alone. On the contrary, it is accompanied by a broad spectrum of other symptoms. Due to its level of inflicted pain, this is also called the “suicide headache.” Most of the victims are men, and it affects fewer than 1% of people. The condition appears and disappears, only to come back again after several months. Once a new wave hits a patient, the person is going to experience repeated sessions of aggressive unilateral headache pain.
The New Device Has No Long-Term Side Effects
The GammaCore device is actually already extremely popular in Europe. However, it was only now when it managed to penetrate the American market. The treatment works by sending electrical stimulation of mild power directly to the vagus nerve. This is the longest nerve of the human body’s nervous system, and it is also the tenth cranial nerve. As soon as patients feel the beginning of cluster headaches, they should apply the device to the neck.
Reports suggest that there are more than 350,000 American citizens who suffer from this condition. Moreover, the new treatment is liable for only mild and momentary side-effects. However, the producer indicated that its device is not for pregnant women, children, and patients with medical implants such as pacemakers.
Image source: 1